106 related articles for article (PubMed ID: 7485095)
1. Serum hyaluronan is increased in malignant lymphoma.
Hasselbalch H; Hovgaard D; Nissen N; Junker P
Am J Hematol; 1995 Dec; 50(4):231-3. PubMed ID: 7485095
[TBL] [Abstract][Full Text] [Related]
2. Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.
Mäenpää H; Ristamäki R; Virtamo J; Franssila K; Albanes D; Joensuu H
Leuk Lymphoma; 2000 May; 37(5-6):585-92. PubMed ID: 11042519
[TBL] [Abstract][Full Text] [Related]
3. [Hyaluronan and CD44 in maternal serum in pre-eclampsia].
Matejevic D; Bussen S; Steck T; Müller T; Dietl J
Z Geburtshilfe Neonatol; 1999; 203(6):246-9. PubMed ID: 10612197
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
5. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
6. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
7. Leucocyte zinc in non-Hodgkin's lymphoma and Hodgkin's disease.
Field HP; Jones R; Walker BE; Kelleher J; Simmons AV
Nutr Cancer; 1988; 11(2):83-92. PubMed ID: 3362723
[TBL] [Abstract][Full Text] [Related]
8. Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.
Dahl IM; Turesson I; Holmberg E; Lilja K
Blood; 1999 Jun; 93(12):4144-8. PubMed ID: 10361111
[TBL] [Abstract][Full Text] [Related]
9. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
Hasselbalch H; Junker P; Lisse I; Lindqvist U; Engström Laurent A
Am J Hematol; 1991 Jan; 36(1):1-8. PubMed ID: 1984676
[TBL] [Abstract][Full Text] [Related]
10. Serum osteopontin and CD44 levels in lymphoreticular malignancies in children.
Elli M; Dagdemir A; Bozkurt C; Pinarli FG; Duzgun A; Ozmen ZC; Ertem U; Acar S
Bratisl Lek Listy; 2012; 113(9):534-8. PubMed ID: 22979908
[TBL] [Abstract][Full Text] [Related]
11. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I.
Mikac-Dević M; Ferenec D; Tiefenbach A
J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):7-10. PubMed ID: 2135960
[TBL] [Abstract][Full Text] [Related]
12. Screening for Celiac disease in Hodgkin and non-Hodgkin lymphoma patients.
Cil T; Altintaş A; Işikdoğan A; Paşa S; Bayan K; Batun S; Büyükbayram H
Turk J Gastroenterol; 2009 Jun; 20(2):87-92. PubMed ID: 19530040
[TBL] [Abstract][Full Text] [Related]
13. Nucleoli of blood monocytes in malignant lymphoma. A morphometric study.
Sokol RJ
Am J Clin Pathol; 1989 Jan; 91(1):60-3. PubMed ID: 2910016
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
15. [Ferritin in the serum of patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma and polycythemia vera].
Kardaszewicz S; Rusinowska Z; Skałba P; Kokocińska D
Pol Tyg Lek; 1988 Feb; 43(7):214-6. PubMed ID: 3405891
[No Abstract] [Full Text] [Related]
16. Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma.
Thylén A; Wallin J; Martensson G
Cancer; 1999 Nov; 86(10):2000-5. PubMed ID: 10570424
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.
Oki Y; Georgakis GV; Migone TS; Kwak LW; Younes A
Haematologica; 2007 Feb; 92(2):269-70. PubMed ID: 17296586
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
